VSEE HEALTH, INC. (VSEE) Form 8-K — Jul 7, 2026
VSee Health, Inc. entered into two separate securities purchase agreements for unsecured convertible note financing, raising an aggregate principal amount of $575,550. The company issued a $280,000 note to ClearThink Capital Partners and a $295,550 note to Vanquish Funding Group, both of which include significant original issue discounts of 10% and 12%, respectively. The ClearThink note matures in June 2027 and is convertible into common stock at 85% of the lowest closing price over the ten trading days prior to conversion notice, subject to a $0.01 floor price.
Key figures
- Debt Amount
- $575,550
- Vanquish Principal
- $295,550
- Clear Think Principal
- $280,000
- Conversion Floor Price
- $0.01
- Vanquish Interest Rate
- 12%
- Vanquish Maturity Date
- April 15, 2027
- Clear Think Interest Rate
- 10%
- Clear Think Maturity Date
- June 22, 2027
- Vanquish Conversion Discount
- 75%
- Clear Think Conversion Discount
- 85%
- Vanquish Original Issue Discount
- $38,550
- Clear Think Original Issue Discount
- $30,000
- Vanquish Additional Tranche Capacity
- $2,050,000
Price after filing
Close on the filing date to close N calendar days later (from $0.11). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.